The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 208 results:
Author Title Type [ Year(Asc)]
Filters: Author is Tziomalos, Konstantinos  [Clear All Filters]
2017
Athyros, V. G., Tziomalos K., Doumas M., Sfikas G., & Karagiannis A. (2017).  The Effect of Proprotein Convertase Subtilisin-Kexin Type 9 and its Inhibition on Glucose Metabolism and Cardiovascular Risk. We Should do Better the Second Time After Statins.. Curr Pharm Des. 23(10), 1477-1483.
Didangelos, T., Tziomalos K., Margaritidis C., Kontoninas Z., Stergiou I., Tsotoulidis S., et al. (2017).  Efficacy of Administration of an Angiotensin Converting Enzyme Inhibitor for Two Years on Autonomic and Peripheral Neuropathy in Patients with Diabetes Mellitus.. J Diabetes Res. 2017, 6719239.
Tziomalos, K., Georgaraki M., Bouziana S. D., Spanou M., Kostaki S., Angelopoulou S-M., et al. (2017).  Impaired kidney function evaluated with the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation is associated with more severe acute ischemic stroke.. Vasc Med. 22(5), 432-434.
Rizos, C. V., Athyros V., Bilianou E., Chrousos G., Garoufi A., Kolovou G., et al. (2017).  An insight into familial hypercholesterolemia in Greece: rationale and design of the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH).. Hormones (Athens). 16(3), 200-204.
Rizos, C. V., Athyros V., Bilianou E., Chrousos G., Garoufi A., Kolovou G., et al. (2017).  An insight into familial hypercholesterolemia in Greece: rationale and design of the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH).. Hormones (Athens). 16(3), 306-312.
Polychronopoulos, G., & Tziomalos K. (2017).  Novel treatment options for the management of heterozygous familial hypercholesterolemia.. Expert Rev Clin Pharmacol. 10(12), 1375-1381.
Hassapidou, M., Tzotzas T., Makri E., Pagkalos I., Kaklamanos I., Kapantais E., et al. (2017).  Prevalence and geographic variation of abdominal obesity in 7- and 9-year-old children in Greece; World Health Organization Childhood Obesity Surveillance Initiative 2010.. BMC Public Health. 17(1), 126.
Makri, E., & Tziomalos K. (2017).  Prevalence, etiology and management of non-alcoholic fatty liver disease in patients with polycystic ovary syndrome.. Minerva Endocrinol. 42(2), 122-131.
Lazaridou, S., Dinas K., & Tziomalos K. (2017).  Prevalence, pathogenesis and management of prediabetes and type 2 diabetes mellitus in patients with polycystic ovary syndrome.. Hormones (Athens). 16(4), 373-380.
Tziomalos, K., Giampatzis V., Bouziana S. D., Spanou M., Kostaki S., Papadopoulou M., et al. (2017).  Prognostic significance of major lipids in patients with acute ischemic stroke.. Metab Brain Dis. 32(2), 395-400.
Ioannidou, E., Tseriotis V-S., & Tziomalos K. (2017).  Role of lipid-lowering agents in the management of diabetic retinopathy.. World J Diabetes. 8(1), 1-6.
Tziomalos, K. (2017).  The Role of Proprotein Convertase Subtilisin-Kexin Type 9 Inhibitors in the Management of Dyslipidemia.. Curr Pharm Des. 23(10), 1495-1499.
Tziomalos, K., Dimitriou P., Bouziana S. D., Spanou M., Kostaki S., Angelopoulou S-M., et al. (2017).  Stress hyperglycemia and acute ischemic stroke in-hospital outcome.. Metabolism. 67, 99-105.
Athyros, V. G., Alexandrides T. K., Bilianou H., Cholongitas E., Doumas M., Ganotakis E. S., et al. (2017).  The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement.. Metabolism. 71, 17-32.
Athyros, V. G., Alexandrides T. K., Bilianou H., Cholongitas E., Doumas M., Ganotakis E. S., et al. (2017).  The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement. Metabolism. 71, 17 - 32.
Alkagiet, S., & Tziomalos K. (2017).  Vascular calcification: the role of microRNAs.. Biomol Concepts. 8(2), 119-123.
2016
Tziomalos, K., Giampatzis V., Bouziana S. D., Spanou M., Kostaki S., Papadopoulou M., et al. (2016).  Acenocoumarol vs. low-dose dabigatran in real-world patients discharged after ischemic stroke.. Blood Coagul Fibrinolysis. 27(2), 185-9.
Tziomalos, K., Giampatzis V., Bouziana S. D., Spanou M., Kostaki S., Papadopoulou M., et al. (2016).  Adequacy of preadmission oral anticoagulation with vitamin K antagonists and ischemic stroke severity and outcome in patients with atrial fibrillation.. J Thromb Thrombolysis. 41(2), 336-42.
Tziomalos, K. (2016).  Adherence to antihyperglycemic treatment: a work in progress.. Expert Opin Pharmacother. 17(12), 1579-80.
Tziomalos, K., Athyros V. G., & Karagiannis A. (2016).  Editorial: Vascular Calcification, Cardiovascular Risk and microRNAs.. Curr Vasc Pharmacol. 14(2), 208-10.
Makri, E., Cholongitas E., & Tziomalos K. (2016).  Emerging role of obeticholic acid in the management of nonalcoholic fatty liver disease.. World J Gastroenterol. 22(41), 9039-9043.
Achimastos, A., Alexandrides T., Alexopoulos D., Athyros V., Bargiota A., Bilianou E., et al. (2016).  Expert consensus on the rational clinical use of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors.. Hormones (Athens). 15(1), 8-14.
Tziomalos, K. (2016).  High-density lipoprotein: quantity or quality?. J Thorac Dis. 8(11), 2975-2977.
Bouziana, S., Tziomalos K., Goulas A., & Ηatzitolios A. Ι. (2016).  The role of adipokines in ischemic stroke risk stratification.. Int J Stroke. 11(4), 389-98.
Tziomalos, K., Giampatzis V., Bouziana S. D., Spanou M., Kostaki S., Papadopoulou M., et al. (2016).  Treatment with Clopidogrel Prior to Acute Non-Cardioembolic Ischemic Stroke Attenuates Stroke Severity.. Cerebrovasc Dis. 41(5-6), 226-32.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.